Method b: Compound 3 (0.3 g, 1.16 mmol) and 3,4-dimethoxybenzaldehyde (0.2 g, 1.2 mmol) according to the
+
+
above method afforded 8e (0.307 g, 65%). Mass spectrum (m/z, %): 405 (56.6) [M] , 404 (100) [M – 1] , 390 (18.8)
+
+
+
+
[M – CH ] , 374 (2.8) [M – OCH ] , 362 (17.5) [M – CH CO] , 347 (2.1) [M – CH CONH] , 332 (1.4), 276 (6.3), 257 (7.7),
3
3
3
3
229 (5.0), 215 (7.0), 182 (12.6), 171 (1.4), 143 (1.4), 119 (4.2), 105 (13.3), 78 (7.0). PMR spectrum (ꢃ, ppm, J/Hz): 8.79 (1H,
s, NH), 8.26 (1H, d, J = 2.4, H-9), 7.80 (1H, dd, J = 8.8, 2.4, H-7), 7.46 (1H, s, CHAr), 7.45 (1H, d, J = 8.9, H-6), 6.96 (1H, dd,
J = 8.5, 2.0, H-6ꢀ), 6.81 (1H, d, J = 2.0, H-2ꢀ), 6.72 (1H, d, J = 8.5, H-5ꢀ), 3.91 (2H, t, J = 5.5, H-1), 3.59 (3H, s, 3ꢀ-OCH ), 3.57
3
(3H, s, 4ꢀ-OCH ), 2.75 (2H, t, J = 5.6, H-3), 2.01 (3H, s, CH CO), 1.86 (2H, m, H-2).
3
3
8-Acetylamino-4-(furfurylidene-2)mackinazolinone (8f). Method a: Compound 4 (0.107 g, 0.5 mmol) and furfurol
3
(0.082 mL, 0.096 g, 1.0 mmol, ꢄ = 1.1598 g/cm ) analogously as above afforded 8f (0.173 g, 89%), mp 273–274°C
(aq. DMF), R 0.66 (system B).
f
3
Method b: Compound 3 (0.3 g, 1.16 mmol) and furfurol (0.11 mL, 0.127 g, 1.3 mmol, ꢄ = 1.1598 g/cm ) afforded 8f
+
+
+
+
(0.32 g, 82%). Mass spectrum (m/z, %): 405 (56.6) [M] , 404 (100) [M – 1] , 390 (18.8) [M – CH ] , 374 (2.8) [M – OCH ] ,
3
3
+
+
362 (17.5) [M – CH CO] , 347 (2.1) [M – CH CONH] , 332 (1.4), 276 (6.3), 257 (7.7), 229 (5.0), 215 (7.0), 182 (12.6), 171
3
3
(1.4), 143 (1.4), 119 (4.2), 105 (13.3), 78 (7.0). PMR spectrum (ꢃ, ppm, J/Hz): 8.78 (1H, s, NH), 8.23 (1H, d, J = 2.3, H-9),
7.79 (1H, dd, J = 9.0, 2.3, H-7), 7.41 (1H, d, J = 9.0, H-6), 7.39 (1H, d, J = 1.7, H-5ꢀ), 7.33 (1H, s, CHHet), 6.71 (1H, d, J = 3.8,
H-3ꢀ), 6.30 (1H, dd, J = 3.8, 1.7, H-4ꢀ), 3.93 (2H, t, J = 5.5, H-1), 2.79 (2H, t, J = 6.8, H-3), 2.00 (3H, s, CH CO), 1.84 (2H, m,
3
H-2).
Mixed samples of compounds 8a–f prepared by methods a and b did not give melting-point depression.
8-Benzoylamino-4-benzylidenemackinazolinone (9a). Compound 5 (0.319 g, 1.0 mmol) dissolved in glacialAcOH
3
(5 mL) was treated with benzaldehyde (0.12 mL, 0.127 g, 1.2 mmol, ꢄ = 1.0498 g/cm ) and refluxed for 3–5 h. The solvent
was distilled off. The solid was recrystallized from MeOH to afford 9a (0.228 g, 56%), mp 226–227°C, R 0.73 (system B).
f
PMR spectrum (ꢃ, ppm, J/Hz): 9.01 (1H, s, NH), 8.43 (1H, d, J = 2.1, H-9), 7.97 (1H, dd, J = 8.9, 2.1, H-7), 7.48–7.54 (4H, m,
CHAr, H-6, 2ꢀ, 6ꢀ), 7.27 (1H, t, J = 7.4, H-4ꢀ), 7.12–7.17 (7H, m, H-3ꢀ, 5ꢀ, 2ꢂ, 3ꢂ, 4ꢂ, 5ꢂ, 6ꢂ), 3.93 (2H, t, J = 5.6, H-1), 2.75 (2H,
t, J = 6.7, H-3), 1.83–1.88 (2H, m, H-2).
8-Benzoylamino-4-(4ꢂ-hydroxybenzylidene)mackinazolinone (9b). Compound 5 (0.319 g, 1.0 mmol) and
4-hydroxybenzaldehyde (0.146 g, 1.2 mmol) afforded analogously as above 9b (0.262 g, 62%), mp 275–276°C (EtOH),
+
+
R 0.84 (system B). Mass spectrum (m/z, %): 423 (91.6) [M] , 335 (11.2), 319 (51.7), 318 (13.3) [M – C H CO] , 281 (11.9),
f
6 5
238 (3.5), 225 (4.2), 198 (3.5), 184 (4.2), 157 (7.0), 133 (14.7), 109 (23.8), 105 (100), 76 (77.6). PMR spectrum (ꢃ, ppm,
J/Hz): 9.02 (1H, s, NH), 8.41 (1H, d, J = 2.0, H-9), 7.96 (1H, dd, J = 9.0, 2.0, H-7), 7.46–7.50 (4H, m, CHAr, H-6, 2ꢀ, 6ꢀ),7.27
(1H, t, J = 7.6, H-4ꢀ), 7.18 (2H, d, J = 8.8, H-2ꢂ, 6ꢂ), 7.14 (2H, t, J = 7.6, H-3ꢀ, 5ꢀ), 6.68 (2H, d, J = 8.8, H-3ꢂ, 5ꢂ), 3.92 (2H, t,
J = 5.5, H-1), 2.72 (2H, t, J = 5.5, H-3), 1.84–1.87 (2H, m, H-2).
8-Benzoylamino-4-(4ꢂ-dimethylaminobenzylidene)mackinazolinone (9c). Compound 5 (0.319 g, 1.0 mmol) and
4-dimethylaminobenzaldehyde (0.178 g, 1.2 mmol) afforded as above 9c (0.254 g, 56%), mp 273–274°C (aq. DMF), R 0.71
f
+
+
+
+
(system B). Mass spectrum (m/z, %): 450 (100) [M] , 449 (92.3) [M – 1] , 435 (1.4) [M – 1] , 345 (8.4) [M – C H CO] , 324
6
5
(1.05), 298 (3.5), 281 (1.0), 253 (1.5), 197 (1.8), 183 (1.4), 145 (1.4), 105 (20.3), 76 (6.3). PMR spectrum (ꢃ, ppm, J/Hz): 9.05
(1H, s, NH), 8.49 (1H, d, J = 2.1, H-9), 7.98 (1H, dd, J = 9.0, 2.1, H-7), 7.50–7.57 (4H, m, CHAr, H-6, 2ꢀ, 6ꢀ), 7.40 (2H, d,
J = 9.0, H-2ꢂ, 6ꢂ), 7.37 (2H, d, J = 9.0, H-3ꢂ, 5ꢂ), 7.27 (1H, t, J = 7.4, H-4ꢀ), 7.15 (2H, t, J = 7.4, H-3ꢀ, 5ꢀ), 3.95 (2H, t, J = 5.7,
H-1), 3.07 [6H, s, N(CH ) ], 2.69 (2H, t, J = 6.4, H-3), 1.84–1.89 (2H, m, H-2).
3 2
8-Benzoylamino-4-(4ꢂ-nitrobenzylidene)mackinazolinone (9d). Compound 5 (0.319 g, 1.0 mmol) and
4-nitrobenzaldehyde (0.166 g, 1.1 mmol) afforded analogously as above 9d (0.303 g, 84%), mp 280–281°C (aq. DMF),
R 0.66 (system B). PMR spectrum (ꢃ, ppm, J/Hz): 9.04 (1H, s, NH), 8.48 (1H, d, J = 2.3, H-9), 8.0 (2H, d, J = 8.9, H-3ꢂ, 5ꢂ),
f
7.97 (1H, dd, J = 8.9, 2.3, H-7), 7.57 (1H, d, J = 8.9, H-6), 7.5 (2H, d, J = 7.6, H-2ꢀ, 6ꢀ), 7.34 (1H, d, J = 8.9, H-2ꢂ, 6ꢂ), 7.27 (1H,
t, J = 7.6, H-4ꢀ), 7.15 (2H, t, J = 7.6, H-3ꢀ, 5ꢀ), 3.95 (2H, t, J = 5.8, H-1), 2.72 (2H, t, J = 5.0, H-3), 1.87–1.90 (2H, m, H-2).
8-Benzoylamino-4-(3ꢂ,4ꢂ-dimethoxybenzylidene)mackinazolinone (9e). Compound 5 (0.319 g, 1.0 mmol) and
3,4-dimethoxybenzaldehyde (0.182 g, 1.1 mmol) afforded analogously as above 9e (0.306 g, 65%), mp 257–258°C (C H ),
6
6
R 0.79 (system B). PMR spectrum (ꢃ, ppm, J/Hz): 9.02 (1H, s, NH), 8.42 (1H, d, J = 2.2, H-9), 7.96 (1H, dd, J = 9.0, 2.2,
f
H-7), 7.48–7.50 (4H, m, CHAr, H-6, 2ꢀ, 6ꢀ), 7.27 (1H, t, J = 7.5, H-4ꢀ), 7.14 (2H, t, J = 7.5, H-3ꢀ, 5ꢀ), 6.97 (1H, dd, J = 8.7, 1.9,
H-6ꢂ), 6.81 (1H, d, J = 1.9, H-2ꢂ), 6.72 (1H, d, J = 8.7, H-5ꢂ), 3.93 (2H, t, J = 5.6, H-1), 3.57 (3H, s, 3ꢂ-OCH ), 3.59 (3H, s,
3
4ꢂ-OCH ), 2.76 (2H, t, J = 5.6, H-3), 1.85–1.89 (2H, m, H-2).
3
8-Benzoylamino-4-(furfurylidene-2)mackinazolinone (9f). Compound 5 (0.319 g, 1.0 mmol) and furfurol
3
0.1 mL (0.116 g, 1.2 mmol, ꢄ = 1.1598 g/cm ) afforded analogously as above 9f (0.342 g, 86%), mp 239–240°C (aq. DMF),
309